IMM 1.49% 34.0¢ immutep limited

Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-3

  1. 601 Posts.
    lightbulb Created with Sketch. 839
    Must agree with your comment above regarding 'late breaking abstract' - as data cut-off was 14th May?
    There is still an embargo on SITC abstracts until 11th November and therefore there will be additional data/info that has not yet been released.
    'Ladenburg Thalman' latest note today:-
    https://hotcopper.com.au/data/attachments/3777/3777107-6839dc1523cc15afbcdb9e3596066a0c.jpg

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.